These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 20682201)

  • 1. Ocular MECP2 protein expression in patients with and without Rett syndrome.
    Jain D; Singh K; Chirumamilla S; Bibat GM; Blue ME; Naidu SR; Eberhart CG
    Pediatr Neurol; 2010 Jul; 43(1):35-40. PubMed ID: 20682201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential brain region-specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey-white matter variation.
    Pejhan S; Siu VM; Ang LC; Del Bigio MR; Rastegar M
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):735-750. PubMed ID: 32246495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis.
    Forlani G; Giarda E; Ala U; Di Cunto F; Salani M; Tupler R; Kilstrup-Nielsen C; Landsberger N
    Hum Mol Genet; 2010 Aug; 19(16):3114-23. PubMed ID: 20504995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
    Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome.
    Miyake K; Hirasawa T; Soutome M; Itoh M; Goto Y; Endoh K; Takahashi K; Kudo S; Nakagawa T; Yokoi S; Taira T; Inazawa J; Kubota T
    BMC Neurosci; 2011 Aug; 12():81. PubMed ID: 21824415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice.
    Lang M; Wither RG; Brotchie JM; Wu C; Zhang L; Eubanks JH
    Hum Mol Genet; 2013 Jan; 22(2):358-71. PubMed ID: 23077217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism.
    Swanberg SE; Nagarajan RP; Peddada S; Yasui DH; LaSalle JM
    Hum Mol Genet; 2009 Feb; 18(3):525-34. PubMed ID: 19000991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
    Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome.
    Tai DJ; Liu YC; Hsu WL; Ma YL; Cheng SJ; Liu SY; Lee EH
    Nat Commun; 2016 Feb; 7():10552. PubMed ID: 26842955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MeCP2 dysfunction in Rett syndrome and related disorders.
    Moretti P; Zoghbi HY
    Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
    Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
    Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
    Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
    Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
    Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
    BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome.
    Okabe Y; Takahashi T; Mitsumasu C; Kosai K; Tanaka E; Matsuishi T
    PLoS One; 2012; 7(4):e35354. PubMed ID: 22532851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of MeCP2 in CNS development and function.
    Na ES; Monteggia LM
    Horm Behav; 2011 Mar; 59(3):364-8. PubMed ID: 20515694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separate respiratory phenotypes in methyl-CpG-binding protein 2 (Mecp2) deficient mice.
    Bissonnette JM; Knopp SJ
    Pediatr Res; 2006 Apr; 59(4 Pt 1):513-8. PubMed ID: 16549521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of MeCP2 in the Rett syndrome and the non-Rett syndrome brain.
    Armstrong DD; Deguchi K; Antallfy B
    J Child Neurol; 2003 Oct; 18(10):683-7. PubMed ID: 14649549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rett syndrome: disruption of epigenetic control of postnatal neurological functions.
    Pohodich AE; Zoghbi HY
    Hum Mol Genet; 2015 Oct; 24(R1):R10-6. PubMed ID: 26060191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation in the gene body influences MeCP2-mediated gene repression.
    Kinde B; Wu DY; Greenberg ME; Gabel HW
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15114-15119. PubMed ID: 27965390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice.
    Jugloff DG; Vandamme K; Logan R; Visanji NP; Brotchie JM; Eubanks JH
    Hum Mol Genet; 2008 May; 17(10):1386-96. PubMed ID: 18223199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.